Anne Wagner, 54, holds a PhD in Biochemical Engineering from the Polytechnical Institute of Lorraine (France) (1990), an Engineers Degree in Biotechnology (1986) and a Masters Degree in Cellular Biology (1986) from the University of Strasbourg (France).
After starting her carrier as a post-doctoral fellow in University College Galway (Ireland) researching in Molecular Biology and teaching, she joined Jungbunzlauer SA in 1993, a leading producer of organic acids and hydrocolloids through fermentation.
From 1996 to 2005, she served as Director Quality and R&D for Syral in Marckolsheim and in 2006 she joined Eli Lilly as Head of the Microbiology Department of the Fegersheim plant (France)- the second biggest parental drug plant of Eli Lilly world wide.
Since 2008, she serves as Vice-President Innovation and Quality for Tereos Syral, the Cereal Division of the Tereos Group.
In 2013, she was appointed Research and Development Director of Tereos.
In parallel, at the incorporation of IMPROVE SAS in July 2013, Anne Wagner was appointed President of the company. She is also in charge of the Presidency of Beghin Meiji (Tereos and Meiji Seika JV) which sales Actilight prebiotic fibers and is a member of various boards: INRA, Escom, ESBS, TWB, CVG, Vitagora.